Department of Immunotechnology
1 – 10 of 1017
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform
- Contribution to journal › Article
-
Mark
Editorial : Allergen-specific antibodies: from basic science to clinical application
- Contribution to journal › Debate/Note/Editorial
-
Mark
In vivo composition of the mitochondrial nucleoid in mice
- Contribution to journal › Article
-
Mark
Altered immune signatures in breast cancer lymph nodes with metastases revealed by spatial proteome analyses
- Contribution to journal › Article
-
Mark
First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies
- Contribution to journal › Article
-
Mark
The Progression of Mycosis Fungoides During Treatment with Mogamulizumab: A BIO-MUSE Case Study of the Tumor and Immune Response in Peripheral Blood and Tissue
- Contribution to journal › Article
-
Mark
Decoding immune heterogeneity in bladder cancer : From cellular cartography to ex vivo models and antibody-based targeting
(2025)
- Thesis › Doctoral thesis (compilation)
-
Mark
REACtiVe-2 : phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer
- Contribution to journal › Article
-
Mark
Sexual dimorphism in zebrafish liver proteins and implications for hepatic regeneration and diseases
- Contribution to journal › Article
-
Mark
Preclinical Validation of [177Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials
(2025) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine
- Contribution to journal › Article
